2010
Elevation of Zinc Transporter ZnT3 Protein in the Cerebellar Cortex of the AβPP/PS1 Transgenic Mouse
Abstract: The presence of senile plaques containing abundant amyloid-beta (Abeta) peptide is one of the major pathological hallmarks of Alzheimer's disease (AD). Recent studies support the notion that overexpression of zinc transporters (ZnT) is involved in zinc metabolic disturbances and Abeta aggregation in AD brains. Here we present data showing an elevated expression of zinc transporter 3 (ZnT3) protein, revealed by immunoblotting assay, in the cerebellum of the amyloid-beta protein precursor (AbetaPP)/presenilin 1 …
Search citation statements
Paper Sections
Select...
16
4
2
1
Citation Types
1
20
0
0
Year Published
Range
2010
2025
Publication Types
Select...
18
1
1
1
Relationship
3
18
Authors
Journals
Cited by 21 publications
(21 citation statements)
References 28 publications
1
20
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…ZnT family member expression is also altered in transgenic mouse models of AD. ZnT1 and ZnT 3-7 protein levels were increased in hippocampus and neocortex of the APPswe/PS1dE9 mouse [31] and increased ZnT3 protein has been reported in APP/PS1 transgenic mouse cerebellum [32]. Taken together, these studies indicate that alterations in ZnT protein expression may be a feature of AD pathology.…”
Section: Introduction
supporting
confidence: 55%
Abstract